Drugs Based Gene Therapy and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Drugs Based on Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs Based on Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs Based on Gene Therapy Overall Market Size
2.1 Global Drugs Based on Gene Therapy Market Size: 2021 VS 2028
2.2 Global Drugs Based on Gene Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs Based on Gene Therapy Players in Global Market
3.2 Top Global Drugs Based on Gene Therapy Companies Ranked by Revenue
3.3 Global Drugs Based on Gene Therapy Revenue by Companies
3.4 Top 3 and Top 5 Drugs Based on Gene Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Drugs Based on Gene Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs Based on Gene Therapy Players in Global Market
3.6.1 List of Global Tier 1 Drugs Based on Gene Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs Based on Gene Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Drugs Based on Gene Therapy Market Size Markets, 2021 & 2028
4.1.2 Based on Viral
4.1.3 Based on Non-viral
4.2 By Type - Global Drugs Based on Gene Therapy Revenue & Forecasts
4.2.1 By Type - Global Drugs Based on Gene Therapy Revenue, 2017-2022
4.2.2 By Type - Global Drugs Based on Gene Therapy Revenue, 2023-2028
4.2.3 By Type - Global Drugs Based on Gene Therapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs Based on Gene Therapy Market Size, 2021 & 2028
5.1.2 Neurological Diseases
5.1.3 Cancer
5.1.4 Other
5.2 By Application - Global Drugs Based on Gene Therapy Revenue & Forecasts
5.2.1 By Application - Global Drugs Based on Gene Therapy Revenue, 2017-2022
5.2.2 By Application - Global Drugs Based on Gene Therapy Revenue, 2023-2028
5.2.3 By Application - Global Drugs Based on Gene Therapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Drugs Based on Gene Therapy Market Size, 2021 & 2028
6.2 By Region - Global Drugs Based on Gene Therapy Revenue & Forecasts
6.2.1 By Region - Global Drugs Based on Gene Therapy Revenue, 2017-2022
6.2.2 By Region - Global Drugs Based on Gene Therapy Revenue, 2023-2028
6.2.3 By Region - Global Drugs Based on Gene Therapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Drugs Based on Gene Therapy Revenue, 2017-2028
6.3.2 US Drugs Based on Gene Therapy Market Size, 2017-2028
6.3.3 Canada Drugs Based on Gene Therapy Market Size, 2017-2028
6.3.4 Mexico Drugs Based on Gene Therapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Drugs Based on Gene Therapy Revenue, 2017-2028
6.4.2 Germany Drugs Based on Gene Therapy Market Size, 2017-2028
6.4.3 France Drugs Based on Gene Therapy Market Size, 2017-2028
6.4.4 U.K. Drugs Based on Gene Therapy Market Size, 2017-2028
6.4.5 Italy Drugs Based on Gene Therapy Market Size, 2017-2028
6.4.6 Russia Drugs Based on Gene Therapy Market Size, 2017-2028
6.4.7 Nordic Countries Drugs Based on Gene Therapy Market Size, 2017-2028
6.4.8 Benelux Drugs Based on Gene Therapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Drugs Based on Gene Therapy Revenue, 2017-2028
6.5.2 China Drugs Based on Gene Therapy Market Size, 2017-2028
6.5.3 Japan Drugs Based on Gene Therapy Market Size, 2017-2028
6.5.4 South Korea Drugs Based on Gene Therapy Market Size, 2017-2028
6.5.5 Southeast Asia Drugs Based on Gene Therapy Market Size, 2017-2028
6.5.6 India Drugs Based on Gene Therapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Drugs Based on Gene Therapy Revenue, 2017-2028
6.6.2 Brazil Drugs Based on Gene Therapy Market Size, 2017-2028
6.6.3 Argentina Drugs Based on Gene Therapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs Based on Gene Therapy Revenue, 2017-2028
6.7.2 Turkey Drugs Based on Gene Therapy Market Size, 2017-2028
6.7.3 Israel Drugs Based on Gene Therapy Market Size, 2017-2028
6.7.4 Saudi Arabia Drugs Based on Gene Therapy Market Size, 2017-2028
6.7.5 UAE Drugs Based on Gene Therapy Market Size, 2017-2028
7 Players Profiles
7.1 Biogen
7.1.1 Biogen Corporate Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Drugs Based on Gene Therapy Major Product Offerings
7.1.4 Biogen Drugs Based on Gene Therapy Revenue in Global Market (2017-2022)
7.1.5 Biogen Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Drugs Based on Gene Therapy Major Product Offerings
7.2.4 Novartis Drugs Based on Gene Therapy Revenue in Global Market (2017-2022)
7.2.5 Novartis Key News
7.3 Gilead Sciences
7.3.1 Gilead Sciences Corporate Summary
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Drugs Based on Gene Therapy Major Product Offerings
7.3.4 Gilead Sciences Drugs Based on Gene Therapy Revenue in Global Market (2017-2022)
7.3.5 Gilead Sciences Key News
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Corporate Summary
7.4.2 Sarepta Therapeutics Business Overview
7.4.3 Sarepta Therapeutics Drugs Based on Gene Therapy Major Product Offerings
7.4.4 Sarepta Therapeutics Drugs Based on Gene Therapy Revenue in Global Market (2017-2022)
7.4.5 Sarepta Therapeutics Key News
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Corporate Summary
7.5.2 Alnylam Pharmaceuticals Business Overview
7.5.3 Alnylam Pharmaceuticals Drugs Based on Gene Therapy Major Product Offerings
7.5.4 Alnylam Pharmaceuticals Drugs Based on Gene Therapy Revenue in Global Market (2017-2022)
7.5.5 Alnylam Pharmaceuticals Key News
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Drugs Based on Gene Therapy Major Product Offerings
7.6.4 Amgen Drugs Based on Gene Therapy Revenue in Global Market (2017-2022)
7.6.5 Amgen Key News
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Corporate Summary
7.7.2 Spark Therapeutics Business Overview
7.7.3 Spark Therapeutics Drugs Based on Gene Therapy Major Product Offerings
7.7.4 Spark Therapeutics Drugs Based on Gene Therapy Revenue in Global Market (2017-2022)
7.7.5 Spark Therapeutics Key News
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Corporate Summary
7.8.2 Akcea Therapeutics Business Overview
7.8.3 Akcea Therapeutics Drugs Based on Gene Therapy Major Product Offerings
7.8.4 Akcea Therapeutics Drugs Based on Gene Therapy Revenue in Global Market (2017-2022)
7.8.5 Akcea Therapeutics Key News
7.9 Bluebird bio
7.9.1 Bluebird bio Corporate Summary
7.9.2 Bluebird bio Business Overview
7.9.3 Bluebird bio Drugs Based on Gene Therapy Major Product Offerings
7.9.4 Bluebird bio Drugs Based on Gene Therapy Revenue in Global Market (2017-2022)
7.9.5 Bluebird bio Key News
7.10 Sunway Biotech
7.10.1 Sunway Biotech Corporate Summary
7.10.2 Sunway Biotech Business Overview
7.10.3 Sunway Biotech Drugs Based on Gene Therapy Major Product Offerings
7.10.4 Sunway Biotech Drugs Based on Gene Therapy Revenue in Global Market (2017-2022)
7.10.5 Sunway Biotech Key News
7.11 SIBIONO
7.11.1 SIBIONO Corporate Summary
7.11.2 SIBIONO Business Overview
7.11.3 SIBIONO Drugs Based on Gene Therapy Major Product Offerings
7.11.4 SIBIONO Drugs Based on Gene Therapy Revenue in Global Market (2017-2022)
7.11.5 SIBIONO Key News
7.12 AnGes
7.12.1 AnGes Corporate Summary
7.12.2 AnGes Business Overview
7.12.3 AnGes Drugs Based on Gene Therapy Major Product Offerings
7.12.4 AnGes Drugs Based on Gene Therapy Revenue in Global Market (2017-2022)
7.12.5 AnGes Key News
7.13 Orchard Therapeutics
7.13.1 Orchard Therapeutics Corporate Summary
7.13.2 Orchard Therapeutics Business Overview
7.13.3 Orchard Therapeutics Drugs Based on Gene Therapy Major Product Offerings
7.13.4 Orchard Therapeutics Drugs Based on Gene Therapy Revenue in Global Market (2017-2022)
7.13.5 Orchard Therapeutics Key News
7.14 Human Stem Cells Institute
7.14.1 Human Stem Cells Institute Corporate Summary
7.14.2 Human Stem Cells Institute Business Overview
7.14.3 Human Stem Cells Institute Drugs Based on Gene Therapy Major Product Offerings
7.14.4 Human Stem Cells Institute Drugs Based on Gene Therapy Revenue in Global Market (2017-2022)
7.14.5 Human Stem Cells Institute Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Drugs Based on Gene Therapy Market Opportunities & Trends in Global Market
Table 2. Drugs Based on Gene Therapy Market Drivers in Global Market
Table 3. Drugs Based on Gene Therapy Market Restraints in Global Market
Table 4. Key Players of Drugs Based on Gene Therapy in Global Market
Table 5. Top Drugs Based on Gene Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Drugs Based on Gene Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Drugs Based on Gene Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Drugs Based on Gene Therapy Product Type
Table 9. List of Global Tier 1 Drugs Based on Gene Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs Based on Gene Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Drugs Based on Gene Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Drugs Based on Gene Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Drugs Based on Gene Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Drugs Based on Gene Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Drugs Based on Gene Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Drugs Based on Gene Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Drugs Based on Gene Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Drugs Based on Gene Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Drugs Based on Gene Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Drugs Based on Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Drugs Based on Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Drugs Based on Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Drugs Based on Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Drugs Based on Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Biogen Corporate Summary
Table 31. Biogen Drugs Based on Gene Therapy Product Offerings
Table 32. Biogen Drugs Based on Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Drugs Based on Gene Therapy Product Offerings
Table 35. Novartis Drugs Based on Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Gilead Sciences Corporate Summary
Table 37. Gilead Sciences Drugs Based on Gene Therapy Product Offerings
Table 38. Gilead Sciences Drugs Based on Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Sarepta Therapeutics Corporate Summary
Table 40. Sarepta Therapeutics Drugs Based on Gene Therapy Product Offerings
Table 41. Sarepta Therapeutics Drugs Based on Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Alnylam Pharmaceuticals Corporate Summary
Table 43. Alnylam Pharmaceuticals Drugs Based on Gene Therapy Product Offerings
Table 44. Alnylam Pharmaceuticals Drugs Based on Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Amgen Corporate Summary
Table 46. Amgen Drugs Based on Gene Therapy Product Offerings
Table 47. Amgen Drugs Based on Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Spark Therapeutics Corporate Summary
Table 49. Spark Therapeutics Drugs Based on Gene Therapy Product Offerings
Table 50. Spark Therapeutics Drugs Based on Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 51. Akcea Therapeutics Corporate Summary
Table 52. Akcea Therapeutics Drugs Based on Gene Therapy Product Offerings
Table 53. Akcea Therapeutics Drugs Based on Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 54. Bluebird bio Corporate Summary
Table 55. Bluebird bio Drugs Based on Gene Therapy Product Offerings
Table 56. Bluebird bio Drugs Based on Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 57. Sunway Biotech Corporate Summary
Table 58. Sunway Biotech Drugs Based on Gene Therapy Product Offerings
Table 59. Sunway Biotech Drugs Based on Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 60. SIBIONO Corporate Summary
Table 61. SIBIONO Drugs Based on Gene Therapy Product Offerings
Table 62. SIBIONO Drugs Based on Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 63. AnGes Corporate Summary
Table 64. AnGes Drugs Based on Gene Therapy Product Offerings
Table 65. AnGes Drugs Based on Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 66. Orchard Therapeutics Corporate Summary
Table 67. Orchard Therapeutics Drugs Based on Gene Therapy Product Offerings
Table 68. Orchard Therapeutics Drugs Based on Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 69. Human Stem Cells Institute Corporate Summary
Table 70. Human Stem Cells Institute Drugs Based on Gene Therapy Product Offerings
Table 71. Human Stem Cells Institute Drugs Based on Gene Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Drugs Based on Gene Therapy Segment by Type in 2021
Figure 2. Drugs Based on Gene Therapy Segment by Application in 2021
Figure 3. Global Drugs Based on Gene Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Drugs Based on Gene Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Drugs Based on Gene Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs Based on Gene Therapy Revenue in 2021
Figure 8. By Type - Global Drugs Based on Gene Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Drugs Based on Gene Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Drugs Based on Gene Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Drugs Based on Gene Therapy Revenue Market Share, 2017-2028
Figure 12. US Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Drugs Based on Gene Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Drugs Based on Gene Therapy Revenue Market Share, 2017-2028
Figure 24. China Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Drugs Based on Gene Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Drugs Based on Gene Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Drugs Based on Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Biogen Drugs Based on Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Drugs Based on Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Gilead Sciences Drugs Based on Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sarepta Therapeutics Drugs Based on Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Alnylam Pharmaceuticals Drugs Based on Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Amgen Drugs Based on Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Spark Therapeutics Drugs Based on Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Akcea Therapeutics Drugs Based on Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bluebird bio Drugs Based on Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sunway Biotech Drugs Based on Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. SIBIONO Drugs Based on Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. AnGes Drugs Based on Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Orchard Therapeutics Drugs Based on Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Human Stem Cells Institute Drugs Based on Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)